Effects of lutein supplement on serum inflammatory cytokines, ApoE and lipid profiles in early atherosclerosis population

Journal of Atherosclerosis and Thrombosis

Volumn 20, Issue 2, 2013, Pages 170-177

  Xu, Xian Rong ^a   Zou, Zhi Yong ^a   Xiao, Xin ^a   Huang, Yang Mu ^a   Wang, Xun ^a   Lin, Xiao Ming ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

ApoE; Cytokines; Early atherosclerosis; LDL; Lutein

Indexed keywords

APOLIPOPROTEIN E; BETA CAROTENE; ENDOTHELIN 1; GAMMA INTERFERON; GLUCOSE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; LYCOPENE; MONOCYTE CHEMOTACTIC PROTEIN 1; PLACEBO; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1; XANTHOPHYLL; ZEAXANTHIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; VITAMIN SUPPLEMENTATION;

AGED; ANTHROPOMETRY; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD GLUCOSE; CHEMOKINE CCL2; CHOLESTEROL, LDL; CYTOKINES; DIET; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INTERVENTION STUDIES; LIPIDS; LIPOPROTEINS, LDL; LUTEIN; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84874413931     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.14365     Document Type: Article

References (39)

1. Lusis AJ: Atherosclerosis. Nature, 2000; 407: 233-241.
2. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ: Global and Regional Burden of Disease and Risk Factors, 2001: Systematic Analysis of Population Health Data. Lancet, 2006; 367: 1747-1757.
3. Rocha VZ, Libby P: Obesity, Inflammation, and Atherosclerosis. Nat Rev Cardiol, 2009; 6: 399-409.
4. Ross R: Atherosclerosis: An Inflammatory Disease. N Engl J Med, 1999; 340: 115-126.
5. Libby P, Ridker PM, Hansson GK: Inflammation in Atherosclerosis: From Pathophysiology to Practice. J Am Coll Cardiol, 2009; 54: 2129-2138.
6. Tedgui A, Mallat Z: Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways. Physiol Rev, 2006; 86: 515-581.
7. Mauriello A, Sangiorgi GM, Virmani R, Trimarchi S, Holmes DR Jr, Kolodgie FD, Piepgras DG, Piperno G, Liotti D, Narula J, Righini P, Ippoliti A, Spagnoli LG: A Pathobiologic Link between Risk Factors Profile and Morphological Markers of Carotid Instability. Atherosclerosis, 2010; 208: 572-580.
8. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ: Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med, 2008; 359: 2195-2207.
9. Voutilainen S, Nurmi T, Mursu J, Rissanen TH: Carotenoids and Cardiovascular Health. Am J Clin Nutr, 2006; 83: 1265-1271.
10. Dwyer JH, Navab M, Dwyer KM, Hassan K, Sun P, Shircore A, Hama-Levy S, Hough G, Wang X, Drake T, Merz CN, Fogelman AM: Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis: The Los Angeles Atherosclerosis Study. Circulation, 2001; 103: 2922-2927.
11. Koh WP, Yuan JM, Wang R, Lee YP, Lee BL, Yu MC, Ong CN: Plasma Carotenoids and Risk of Acute Myocardial Infarction in the Singapore Chinese Health Study. Nutr Metab Cardiovasc Dis, 2011; 21: 685-690.
12. Kim JE, Leite JO, DeOgburn R, Smyth JA, Clark RM, Fernandez ML: A Lutein-Enriched Diet Prevents Cholesterol Accumulation and Decreases Oxidized LDL and Inflammatory Cytokines in the Aorta of Guinea Pigs. J Nutr, 2011; 141: 1458-1463.
13. Iribarren C, Folsom AR, Jacobs DR Jr, Gross MD, Belcher JD, Eckfeldt JH: Association of Serum Vitamin Levels, LDL Susceptibility to Oxidation, and Autoantibodies against MDA-LDL with Carotid Atherosclerosis. A Case-Control Study. The Aric Study Investigators. Atherosclerosis Risk in Communities. Arterioscler Thromb Vasc Biol, 1997; 17: 1171-1177.
14. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, Stampfer MJ: Prospective Study of Plasma Carotenoids and Tocopherols in Relation to Risk of Ischemic Stroke. Stroke, 2004; 35: 1584-1588.
15. Zou Z, Xu X, Huang Y, Xiao X, Ma L, Sun T, Dong P, Wang X, Lin X: High Serum Level of Lutein May Be Protective against Early Atherosclerosis: The Beijing Atheromacrophages, sclerosis Study. Atherosclerosis, 2011; 219: 789-793.
16. Dogan S, Kastelein JJ, Grobbee DE, Bots ML: Mean Common or Mean Maximum Carotid Intima-Media Thickness as Primary Outcome in Lipid-Modifying Intervention Studies. J Atheroscler Thromb, 2011; 18: 946-957.
17. Yeum KJ, Booth SL, Sadowski JA, Liu C, Tang G, Krinsky NI, Russell RM: Human Plasma Carotenoid Response to the Ingestion of Controlled Diets High in Fruits and Vegetables. Am J Clin Nutr, 1996; 64: 594-602.
18. Institute of Nutrition and Food Safety, Center of Disease Control: China Food Composition. Peking University Medical Press, Beijing, 2004.
19. Gao YY, Xie QM, Jin L, Sun BL, Ji J, Chen F, Ma JY, Bi YZ: Supplementation of Xanthophylls Decreased Proinflammatory and Increased Anti-Inflammatory Cytokines in Hens and Chicks. Br J Ntur, 2012; Jan 25: 1-10. [Epub ahead of print]
20. Schuett H, Luchtefeld M, Grothusen C, Grote K, Schieffer B: How Much Is Too Much? Interleukin-6 and Its Signalling in Atherosclerosis. Thromb Haemost, 2009; 102: 215-222.
21. Boekholdt SM, Stroes ES: The Interleukin-6 Pathway and Atherosclerosis. Lancet, 2012; 379: 1176-1178.
22. Danesh J, Kaptoge S, Mann AG, Sarwar N, Wood A, Angleman SB, Wensley F, Higgins JP, Lennon L, Eiriksdottir G, Rumley A, Whincup PH, Lowe GD, Gudnason V: Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review. PLoS Med, 2008; 5: e78.
23. Rydén M, Garvin P, Kristenson M, Leanderson P, Ernerudh J, Jonasson L: Provitamin a Carotenoids Are Independently Associated with Matrix Metalloproteinase-9 in Plasma Samples from a General Population. J Intern Med, 2012; Feb 28. doi: 10.1111/j.1365-2796.2012.2534x.x. [Epub ahead of print]
24. Moore KJ, Tabas I: Macrophages in the Pathogenesis of Atherosclerosis. Cell, 2011; 145: 341-355.
25. Mestas J, Ley K: Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis. Trends Cardiovasc Med, 2008; 18: 228-232.
26. Yadav A, Saini V, Arora S: MCP-1: Chemoattractant with a Role Beyond Immunity: A Review. Clin Chim Acta, 2010; 411: 1570-1579.
27. Mitra S, Deshmukh A, Sachdeva R, Lu J, Mehta JL: Oxidized Low-Density Lipoprotein and Atherosclerosis Implications in Antioxidant Therapy. Am J Med Sci, 2011; 342: 135-142.
28. Mizuno K, Nakaya N, Teramoto T, Yokoyama S, Ohashi Y, Ueki A, Takahashi S, Kubota Y, Nakamura H: Usefulness of LDL-C-Related Parameters to Predict Cardiovascular Risk and Effect of Pravastatin in Mild-to-Moderate Hypercholesterolemia. J Atheroscler Thromb, 2012; 19: 176-185.
29. Nissen SE, Tuzcu EM, Schoenhagen P, Crowe T, Sasiela WJ, Tsai J, Orazem J, Magorien RD, O'Shaughnessy C, Ganz P, Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) Investigators: Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease. N Engl J Med, 2005; 352: 29-38.
30. Nissen SE, Nicholls SJ, Sipahi I, Libby P, Raichlen JS, Ballantyne CM, Davignon J, Erbel R, Fruchart JC, Tardif JC, Schoenhagen P, Crowe T, Cain V, Wolski K, Goormastic M, Tuzcu EM, ASTEROID Investigators: Effect of Very High-Intensity Statin Therapy on Regression of Coronary Atherosclerosis: The Asteroid Trial. JAMA, 2006; 295: 1556-1565.
31. Yang Y, Seo JM, Nguyen A, Pham TX, Park HJ, Park Y, Kim B, Bruno RS, Lee J: Astaxanthin-Rich Extract from the Green Alga Haematococcus Pluvialis Lowers Plasma Lipid Concentrations and Enhances Antioxidant Defense in Apolipoprotein E Knockout Mice. J Nutr, 2011; 141: 1611-1617.
32. Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, Tada N: Administration of Natural Astaxanthin Increases Serum HDL-Cholesterol and Adiponectin in Subjects with Mild Hyperlipidemia. Atherosclerosis, 2010; 209: 520-523.
33. Santocono M, Zurria M, Berrettini M, Fedeli D, Falcioni G: Influence of Astaxanthin, Zeaxanthin and Lutein on DNA Damage and Repair in Uva-Irradiated Cells. J Photochem Photobiol B, 2006; 85: 205-215.
34. Huang Y: Mechanisms Linking Apolipoprotein E Isoforms with Cardiovascular and Neurological Diseases. Curr Opin Lipidol 2010; 21: 337-345.
35. Huang Y, Liu XQ, Rall SC Jr, Taylor JM, von Eckardstein A, Assmann G, Mahley RW: Overexpression and Accumulation of Apolipoprotein E as a Cause of Hypertriglyceridemia. J Biol Chem, 1998; 273: 26388-26393.
36. Mahley RW: Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology. Science, 1988; 240: 622-630.
37. Christopher K. Glass, Witztum JL: Atherosclerosis: The Road Ahead. Cell, 2001; 104: 503-516.
38. Bian Q, Qin T, Ren Z, Wu D, Shang F: Lutein or Zeaxanthin Supplementation Suppresses Inflammatory Responses in Retinal Pigment Epithelial Cells and Macrophages. Adv Exp Med Biol, 2012; 723: 43.
39. Skaug EA, Aspenes ST, Oldervoll L, Mørkedal B, Vatten L, Wisløff U, Ellingsen O: Age and Gender Differences of Endothelial Function in 4739 Healthy Adults: The Hunt3 Fitness Study. Eur J Prev Cardiolog, 2012; [Epub ahead of print]